018297329

Kyverna

---

August 27, 2020

Trademark Summary

The trademark application Kyverna was filed by Kyverna Therapeutics, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on September 30, 2020, and it was registered by office on January 8, 2021 without any oppositions.

The application was filed in English (German was selected as the second language).

Change of name and address of the trademark registration was recorded on April 5, 2021.

---

Goods And Services

• The mark was filed in class 5 with following description of goods:
  
  1. Pharmaceuticals
  2. Pharmaceutical preparations
  3. Therapeutic pharmaceuticals for the treatment of autoimmune disease
  4. Pharmaceutical therapeutic agents for medical use
  5. Cell therapy products for the treatment of autoimmune disease
  6. Cells for medical use
  7. Living cells for medical use
  8. Therapeutic pharmaceuticals and cell therapy products in the nature of cells for medical or clinical use for the treatment of autoimmune disease
  9. Cell therapy products, namely, genetically engineered immune cells for the treatment of autoimmune disease
  10. Cell therapy products, namely, genetically engineered immune cells for medical or clinical use for the treatment of autoimmune disease
  11. Antibodies
  12. Antibody receptors
  13. Antigens
  14. Antigen receptors
  15. Diagnostic agents, preparations and substances for medical purposes
  16. Pharmaceutical products, namely, diagnostic reagents for medical purposes
  17. Control reagents for medical laboratory purposes
  18. Control reagents for clinical medical purposes.
• The mark was filed in class 42 with following description of goods:
  
  1. Scientific and technological services and research and design relating thereto
  2. Industrial analysis and research services
  3. Research, development, testing and evaluation of pharmaceuticals, pharmaceutical preparations and pharmaceutical therapeutic agents
  4. Research, development, testing and evaluation of medical preparations, cells for medical use, antibodies, antibody receptors, antigens and antigen receptors
  5. Medical research and development
  6. Medical and scientific research and development in the field of diagnosis and treatment of autoimmune disease
  7. Research, development, testing and evaluation of diagnostic agents, preparations and substances for medical purposes
  8. Information, advice and consultancy regarding the aforementioned services.
• The mark was filed in class 44 with following description of goods:
  
  1. Medical services
  2. Medical information services
  3. Medical testing services
  4. Medical diagnostic testing services
  5. Medical treatment services
  6. Medical services for the diagnosis and treatment of autoimmune disease
  7. Medical services, namely, cell based therapies
  8. Information, advice and consultancy regarding the aforementioned services.